Senseonics Holdings Inc (SENS)
0.3184
0.00 (0.00%)
USD |
NYAM |
Nov 22, 13:22
Senseonics Holdings Total Liabilities (Quarterly): 113.51M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 113.51M |
| June 30, 2024 | 110.98M |
| March 31, 2024 | 107.55M |
| December 31, 2023 | 102.42M |
| September 30, 2023 | 102.00M |
| June 30, 2023 | 100.82M |
| March 31, 2023 | 94.07M |
| December 31, 2022 | 180.25M |
| September 30, 2022 | 197.74M |
| June 30, 2022 | 159.38M |
| March 31, 2022 | 277.57M |
| December 31, 2021 | 384.46M |
| September 30, 2021 | 486.27M |
| June 30, 2021 | 547.76M |
| March 31, 2021 | 381.85M |
| December 31, 2020 | 180.00M |
| September 30, 2020 | 98.84M |
| June 30, 2020 | 80.44M |
| March 31, 2020 | 84.23M |
| December 31, 2019 | 141.45M |
| Date | Value |
|---|---|
| September 30, 2019 | 141.70M |
| June 30, 2019 | 83.22M |
| March 31, 2019 | 85.46M |
| December 31, 2018 | 88.71M |
| September 30, 2018 | 106.73M |
| June 30, 2018 | 102.95M |
| March 31, 2018 | 90.99M |
| December 31, 2017 | 38.68M |
| September 30, 2017 | 37.89M |
| June 30, 2017 | 35.13M |
| March 31, 2017 | 33.07M |
| December 31, 2016 | 27.15M |
| September 30, 2016 | 23.79M |
| June 30, 2016 | 24.23M |
| March 31, 2016 | 18.67M |
| September 30, 2015 | 0.0491M |
| June 30, 2015 | 0.0465M |
| March 31, 2015 | 0.0186M |
| December 31, 2014 | 0.0194M |
| September 30, 2014 | 0.019M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
80.44M
Minimum
Jun 2020
547.76M
Maximum
Jun 2021
196.58M
Average
127.48M
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 34.33B |
| DexCom Inc | 4.375B |
| Baxter International Inc | 18.73B |
| Boston Scientific Corp | 17.12B |
| Perspective Therapeutics Inc | 62.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.33M |
| Shareholders Equity (Quarterly) | -17.18M |
| Debt to Equity Ratio | -3.133 |
| Current Ratio | 2.470 |
| Net Debt Paydown Yield | -1.54% |